Chen_2024_J.Enzyme.Inhib.Med.Chem_39_2398561

Reference

Title : Discovery of natural anthraquinones as potent inhibitors against pancreatic lipase: structure-activity relationships and inhibitory mechanism - Chen_2024_J.Enzyme.Inhib.Med.Chem_39_2398561
Author(s) : Chen ZQ , He WY , Yang SY , Ma HH , Zhou J , Li H , Zhu YD , Qian XK , Zou LW
Ref : J Enzyme Inhib Med Chem , 39 :2398561 , 2024
Abstract :

Obesity is acknowledged as a significant risk factor for various metabolic diseases, and the inhibition of human pancreatic lipase (hPL) can impede lipid digestion and absorption, thereby offering potential benefits for obesity treatment. Anthraquinones is a kind of natural and synthetic compounds with wide application. In this study, the inhibitory effects of 31 anthraquinones on hPL were evaluated. The data shows that AQ7, AQ26, and AQ27 demonstrated significant inhibitory activity against hPL, and exhibited selectivity towards other known serine hydrolases. Then the structure-activity relationship between anthraquinones and hPL was further analysed. AQ7 was found to be a mixed inhibition of hPL through inhibition kinetics, while AQ26 and AQ27 were effective non-competitive inhibition of hPL. Molecular docking data revealed that AQ7, AQ26, and AQ27 all could associate with the site of hPL. Developing hPL inhibitors for obesity prevention and treatment could be simplified with this novel and promising lead compound.

PubMedSearch : Chen_2024_J.Enzyme.Inhib.Med.Chem_39_2398561
PubMedID: 39223707

Related information

Inhibitor Alizarin
Substrate DDAO-ol

Citations formats

Chen ZQ, He WY, Yang SY, Ma HH, Zhou J, Li H, Zhu YD, Qian XK, Zou LW (2024)
Discovery of natural anthraquinones as potent inhibitors against pancreatic lipase: structure-activity relationships and inhibitory mechanism
J Enzyme Inhib Med Chem 39 :2398561

Chen ZQ, He WY, Yang SY, Ma HH, Zhou J, Li H, Zhu YD, Qian XK, Zou LW (2024)
J Enzyme Inhib Med Chem 39 :2398561